The FDA’s recent approval of Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, a once-daily GLP-1 receptor agonist injection, is a significant milestone. This drug, indicated for glycemic… Continue reading FDA Approves Hikma’s Generic Version of GLP-1 Diabetes Drug Victoza
On August 26, the U.S. Food and Drug Administration (FDA) approved Insulet’s SmartAdjust technology for managing type 2 diabetes in patients aged 18 and above. Earlier, this interoperable automated glycemic… Continue reading FDA Approves First Device to Enable Automated Insulin Dosing for Individuals with Type 2 Diabetes
Bengaluru-based biopharmaceutical company Biocon has inked a pact with Brazil-based Biomm SA to commercialize its diabetes treatment in the Latin American nation. As per the MoU, Biocon will focus on… Continue reading Biocon, Biomm: Diabetes Drug Licensing Deal for Brazil
Shoppers Drug Mart Inc. is taking significant steps toward its commitment to reducing plastic waste with the launch of the “Quo Beauty Cosmetics Free Recycling Program”. The Canadian retail pharmacy… Continue reading Shoppers Drug Mart partners with TerraCycle® for cosmetics recycling
On March 19, the FDA granted approval to Orchard Therapeutics’ gene-edited cell therapy atidarsagene autotemcel (now branded as Lenmeldy in the U.S.) for treating children with metachromatic leukodystrophy (MLD). It… Continue reading USFDA approves Orchard Therapeutics’ gene therapy for childhood MLD
Breye Therapeutics ApS (Breye), a leading clinical-stage biopharma company headquartered in Denmark, has initiated a phase 1b/2a clinical trial to check the safety, side effects, and dosage of danegaptide, administered… Continue reading Breye Therapeutics: Oral Danegaptide in DME Trial
Summary: There has been a ceaseless development in gene modification strategy beginning from restriction endonucleases, transgenic breeding, and RNAi advances to the currently engineered endonucleases. Over the last few decades,… Continue reading In-depth Analysis- CRISPR/Cas9 Technology
The global battery-free implants market was valued at $XX billion in 2016 and is forecast to exceed XX billion by 2023 at a Compound Annual Growth Rate (CAGR) of XX%.… Continue reading Battery Free Implants: Technology and Market Report
On 29th June Cipla Limited and Boehringer Ingelheim India Pvt. Ltd. Announced their partnership in India to co-market there 3 new oral anti-diabetic drugs named Oboravo (Empagliflozin), Tiptengio (Empagliflozin +… Continue reading Cipla, Boehringer: Co-Marketing 3 Oral Anti-Diabetic Drugs
“As the world grapples with COVID-19, every ounce of technological innovation and ingenuity harnessed to fight this pandemic brings us one step closer to overcoming it. AI and ML are… Continue reading Nagarro launches AI solution to reduce COVID-19 risks at work
